Search clinical trials for: SR57667B

Total 4 results

Sanofi

Completed

Study of the Effect of SR57667B in Patients With Alzheimer's Disease

Alzheimer Disease
Sanofi

Completed

Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease

Alzheimer Disease

France, Canada, Germany, Sweden, Finland, South Africa, Denmark
Sanofi

Completed

Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease

Parkinson Disease

France, Canada, Netherlands, Spain, Switzerland, Finland, United Kingdom
Sanofi

Completed

Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease

Parkinson Disease

France, Canada, Germany, Netherlands, Portugal, Spain, Sweden, Tunisia, Denmark, Morocco, South Africa, Austria, United Kingdom

3

Subscribe